Could a tiny dose of naltrexone ease HIV nerve pain?

NCT ID NCT05537935

First seen Apr 17, 2026 · Last updated May 14, 2026 · Updated 4 times

Summary

This study tests whether a low dose of naltrexone (LDN) can reduce chronic nerve pain in people with HIV. About 60 adults with HIV and neuropathic pain will take LDN for 12 weeks while researchers track pain scores and CD4 counts. The goal is to find a safer, non-opioid option for pain relief.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory Midtown Hospital

    RECRUITING

    Atlanta, Georgia, 30308, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Emory University Hospital

    RECRUITING

    Atlanta, Georgia, 30322, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Grady Memorial Hospital

    RECRUITING

    Atlanta, Georgia, 30303, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.